Research in Dublin
Science Explorer records 9 research institutions in Dublin, United States. The highest-ranked on research quality in 2022–2025 are Cardinal Health (United States).
- Research institutions
- 9 1 of them ranked worldwide
- Research works
- 752 ▲ 79% vs 2013–17
- Top-10% rate, 2022–2025
- 6.2% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Dublin?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Cardinal Health (United States)Company | 446 | #24,943 | |
| 2 | Center for Reliable Energy SystemsResearch facility | 68 | not ranked | |
| 3 | Guild Associates (United States)Company | 67 | not ranked | |
| 4 | Navidea Biopharmaceuticals (United States)Company | 49 | not ranked | |
| 5 | LSP Technologies (United States)Company | 47 | not ranked | |
| 6 | Ohio Sinus InstituteHospital / health system | 42 | not ranked | |
| 7 | Ohio Pain InitiativeHospital / health system | 19 | not ranked | |
| 8 | Samraksh (United States)Company | 11 | not ranked | |
| 9 | Columbus Ophthalmology AssociatesInstitution | 4 | not ranked |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
How concentrated the city is
The same institutions as shares of everything the list accounts for. A city that is one university and a city that is twelve read alike as a table and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which keywords describe research in Dublin?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Prognostic Factors, Clinical Trials, Lymphoma, Targeted Therapy, Cancer Immunotherapy, Tumor Regression and Quality of Life.
- Metastatic Breast Cancer
- BCR-ABL
- PD-1 and PD-L1
- Neoadjuvant Therapy
- EGFR Mutations
- ALK Inhibitors
- Proteasome Inhibitors
- Rituximab
- Genomic Profiling
- Health Utility Measures
- Radiotherapy
- Minimal Residual Disease
- Cost of Care
- CAR T Cells
- Public Health
- Cancer Immunotherapy
- Targeted Therapy
- Clinical Trials
- Epidemiology
- Machine Learning
- Immunotherapy
- Quality of Life
- Prognostic Factors
- Lymphoma
- Chemotherapy
- Tumor Regression
- Leukemia
- Chimeric Antigen Receptor
- Financial Toxicity
- Precision Medicine
- Cost-effectiveness Analysis
- Treatment Guidelines
- Feature Extraction
- Mutation
- Staging System
- Diagnosis Criteria
- International Myeloma Working Group
- Immune Checkpoint Blockade
- Predictive Modeling
- Imatinib
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy10▲ 9.5×12 topics
- Machine Learning8▲ 1.61×21 topics
- Quality of Life8▲ 3.6×11 topics
- Epidemiology8▲ 1.30×30 topics
- Prognostic Factors8▲ 12×8 topics
- Clinical Trials8▲ 7.5×8 topics
- Lymphoma7▲ 30×3 topics
- Targeted Therapy7▲ 19×4 topics
- Chemotherapy6▲ 5.5×14 topics
- Cancer Immunotherapy6▲ 25×2 topics
- Tumor Regression6▲ 35×2 topics
- Public Health6▲ 2.5×13 topics
- Leukemia5▲ 42×2 topics
- CAR T Cells5▲ 47×1 topic
- Chimeric Antigen Receptor5▲ 47×1 topic
- Cost of Care5▲ 100×1 topic
- Financial Toxicity5▲ 100×1 topic
- Minimal Residual Disease4▲ 40×2 topics
- Precision Medicine4▲ 6.0×6 topics
- Radiotherapy4▲ 7.2×6 topics
- Cost-effectiveness Analysis4▲ 32×1 topic
- Health Utility Measures4▲ 32×1 topic
- Treatment Guidelines4▲ 11×3 topics
- Genomic Profiling4▲ 22×2 topics
- Feature Extraction3▲ 4.8×4 topics
- Rituximab3▲ 14×2 topics
- Mutation3▲ 11×2 topics
- Proteasome Inhibitors3▲ 29×2 topics
- Staging System3▲ 33×2 topics
- ALK Inhibitors3▲ 31×1 topic
- Diagnosis Criteria3▲ 56×1 topic
- EGFR Mutations3▲ 31×1 topic
- International Myeloma Working Group3▲ 56×1 topic
- Neoadjuvant Therapy3▲ 8.2×3 topics
- Immune Checkpoint Blockade3▲ 16×1 topic
- PD-1 and PD-L13▲ 16×1 topic
- Predictive Modeling3▲ 6.7×4 topics
- BCR-ABL3▲ 66×1 topic
- Imatinib3▲ 66×1 topic
- Metastatic Breast Cancer2▲ 29×2 topics
What research is done in Dublin?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 5 works
- 2 Economic and Financial Impacts of Cancer Economics and Econometrics 5 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 5 Multiple Myeloma Research and Treatments Hematology 3 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 7 Chronic Myeloid Leukemia Treatments Hematology 3 works
- 8 Cancer Genomics and Diagnostics Cancer Research 2 works
- 9 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
- 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.